All News

In Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.

Nonadherence to treatment plans is a contributing factor in for many second myocardial infarctions.

PBMs are evolving, but what will they be evolving into and will they be more transparent?

Neratinib (Nerlynx) is an extended adjuvant treatment for patients with early stage HER2 positive breast cancer who are receiving trastuzumab therapy.

Opioid limits are gaining popularity, but do they actually work?

Technology can help reduce error rates in IV compounding.

Ransomware and cybersecurity threats expose patients to risks.

It's no news that pharmacists are stressed, but how is it affecting job performance-and how do pharmacists cope?

Check out the latest changes to the Express Scripts formulary

Not all drugs are incredible-and sometimes even the incredible ones have weird origins.

The FIP awards honored two international pharmacy associations for their recent campaigns.

Rivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.

EpiPen manufacturer is accused of lax investigation into problems.

Education about anticoagulants helped boost adherence rates and led to a small decrease in stroke risk.

Sodium polystyrene sulfonate interferes with many oral drugs and should be dosed separately.

The use of health IT has exploded in the last decade, and that means better health care.

After trials halted, FDA issues warning on off-label use of the drug.

After Mylotarg was taken voluntarily taken off the market, the FDA is giving it a second chance.

The city's decision is the latest move against tobacco in pharmacies.

Mid Valley Pharmaceutical recalls two drugs.

A petition sent by multiple groups says yes.

In the midst of unprecedented disaster, pharmacists and pharmacies were prepared.

Why the agency says the approval of Novartis’ new therapy is historic.

New therapies hold great promise-and great danger.

The recall is just the latest in a bacterial contamination scare.

Robberies are never a good thing, but sometimes they make for the craziest stories.

An opioid scheme ends in prison and hefty fines.

Why the NABP says Canada isn't a safe alternative.